« « Diabetes management products covered in Sweet magazine by Sue Marshall – Response Source (press release) 
|  Plastic Chemical Linked To Diabetes And Heart Disease – eFluxMedia » »
GlaxoSmithKline receives Avandia boost from diabetes study – Forbes
Monday, September 22nd, 2008    Subscribe To Our Feed|
GlaxoSmithKline receives Avandia boost from diabetes study
Forbes, NY - 9 hours ago LONDON (Thomson Financial) – GlaxoSmithKline Plc, Europe's biggest drugmaker, received a boost on Friday after a key US diabetes study said that its … |
Source:GlaxoSmithKline receives Avandia boost from diabetes study – Forbes
Posted in insulin | Trackback | del.icio.us | Top Of Page
Site Search Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Technorati Tags: No Tags
Related Tags: No Tags
Possible Related Posts
Glaxo's diabetes drug falls short on heart disease – Boston GlobeSector Snap: Diabetes treatment guidelines change – ForbesDiabetes Casualty – Forbes